Wafaa M. Ezzat

692 total citations
43 papers, 526 citations indexed

About

Wafaa M. Ezzat is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Wafaa M. Ezzat has authored 43 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 13 papers in Hepatology and 11 papers in Molecular Biology. Recurrent topics in Wafaa M. Ezzat's work include Liver Disease Diagnosis and Treatment (21 papers), MicroRNA in disease regulation (9 papers) and Hepatitis C virus research (8 papers). Wafaa M. Ezzat is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), MicroRNA in disease regulation (9 papers) and Hepatitis C virus research (8 papers). Wafaa M. Ezzat collaborates with scholars based in Egypt, United States and Germany. Wafaa M. Ezzat's co-authors include Khalda Amr, Refaat Kamel, Leonardo Bianchi, Khalifa Khalifa, Sanaa M. Kamal, Thomas Peter, J. Rasenack, Margaret James Koziel, Hala M. Raslan and Moushira Zaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Hepatology.

In The Last Decade

Wafaa M. Ezzat

41 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wafaa M. Ezzat Egypt 13 204 191 159 152 55 43 526
Shuangsuo Dang China 12 161 0.8× 126 0.7× 202 1.3× 115 0.8× 22 0.4× 43 523
Yuki Haga Japan 14 326 1.6× 284 1.5× 119 0.7× 78 0.5× 20 0.4× 48 586
Yuta Wakui Japan 13 276 1.4× 199 1.0× 88 0.6× 33 0.2× 28 0.5× 23 467
Te‐Sheng Chang Taiwan 14 305 1.5× 278 1.5× 154 1.0× 109 0.7× 27 0.5× 50 678
José María Vera-Cruz Mexico 10 282 1.4× 250 1.3× 124 0.8× 47 0.3× 23 0.4× 13 563
Shin Fujioka Japan 11 206 1.0× 140 0.7× 153 1.0× 40 0.3× 17 0.3× 36 479
Takeshi Urabe Japan 16 175 0.9× 239 1.3× 125 0.8× 54 0.4× 55 1.0× 67 652
Jin Ye China 8 283 1.4× 297 1.6× 122 0.8× 34 0.2× 17 0.3× 18 575
Janett Fischer Germany 13 517 2.5× 383 2.0× 66 0.4× 27 0.2× 47 0.9× 42 640

Countries citing papers authored by Wafaa M. Ezzat

Since Specialization
Citations

This map shows the geographic impact of Wafaa M. Ezzat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wafaa M. Ezzat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wafaa M. Ezzat more than expected).

Fields of papers citing papers by Wafaa M. Ezzat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wafaa M. Ezzat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wafaa M. Ezzat. The network helps show where Wafaa M. Ezzat may publish in the future.

Co-authorship network of co-authors of Wafaa M. Ezzat

This figure shows the co-authorship network connecting the top 25 collaborators of Wafaa M. Ezzat. A scholar is included among the top collaborators of Wafaa M. Ezzat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wafaa M. Ezzat. Wafaa M. Ezzat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vishwanathaiah, Satish, Wafaa M. Ezzat, Natheer Al‐Rawi, et al.. (2024). Color perception and its relation to dental anxiety in children. Dental and Medical Problems. 61(5). 671–677. 1 indexed citations
2.
Ezzat, Wafaa M., et al.. (2023). Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease. Journal of Genetic Engineering and Biotechnology. 21(1). 13–13. 5 indexed citations
3.
Youness, Eman R., et al.. (2023). Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes. Diabetology & Metabolic Syndrome. 15(1). 52–52. 4 indexed citations
4.
Ezzat, Wafaa M., et al.. (2019). Efficacy and Safety of Microwave Ablation (MWA) for Hepatocellular Carcinoma (HCC) in Difficult Anatomical Sites in Egyptian Patients with Liver Cirrhosis. Asian Pacific Journal of Cancer Prevention. 20(1). 295–301. 17 indexed citations
5.
Ezzat, Wafaa M., et al.. (2019). Detection of DNA methylated microRNAs in hepatocellular carcinoma. Gene. 702. 153–157. 5 indexed citations
6.
7.
Borai, Ibrahim H., et al.. (2017). Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 5(2). 109–118. 15 indexed citations
8.
9.
10.
Ezzat, Wafaa M., et al.. (2016). Relationship Between Serum microRNA155 and Telomerase Expression in Hepatocellular Carcinoma. Archives of Medical Research. 47(5). 349–355. 10 indexed citations
11.
Ezzat, Wafaa M., et al.. (2016). Diagnostic Accuracy of Acoustic Radiation Force Impulse (ARFI) in Diagnosis of Liver Fibrosis among Egyptian Patients with Chronic HCV Infection. Open Access Macedonian Journal of Medical Sciences. 4(3). 374–380. 6 indexed citations
12.
Kamel, Refaat, et al.. (2016). Relation between microRNAs and Apoptosis in Hepatocellular Carcinoma. Open Access Macedonian Journal of Medical Sciences. 4(1). 31–37. 15 indexed citations
13.
Amr, Khalda, et al.. (2015). The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma. Gene. 575(1). 66–70. 56 indexed citations
14.
Zaki, Moushira, et al.. (2013). Factors Associated With Nonalcoholic Fatty Liver Disease in Obese Adolescents. Macedonian Journal of Medical Sciences. 6(3). 4 indexed citations
15.
Ezzat, Wafaa M., et al.. (2012). Insulin resistance and early virological response in chronic HCV infection. Journal of Genetic Engineering and Biotechnology. 11(1). 69–73. 3 indexed citations
16.
Raslan, Hala M., et al.. (2011). Possible role of angiotensin-converting enzyme polymorphism on progression of hepatic fibrosis in chronic hepatitis C virus infection. Transactions of the Royal Society of Tropical Medicine and Hygiene. 105(7). 396–400. 3 indexed citations
17.
Raslan, Hala M., et al.. (2010). The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt. Transactions of the Royal Society of Tropical Medicine and Hygiene. 104(6). 429–432. 15 indexed citations
18.
Ezzat, Wafaa M., et al.. (2009). Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy. Rheumatology International. 31(1). 65–69. 19 indexed citations
19.
Raslan, Hala M., et al.. (2007). Original paper Insulin growth factor-1 and insulin growth factor binding protein-3 in Egyptian patients with chronic hepatitis C. Archives of Medical Science. 3(1). 46–51. 4 indexed citations
20.
Kamal, Sanaa M., J. Rasenack, Leonardo Bianchi, et al.. (2001). Acute hepatitis C without and with schistosomiasis: Correlation with hepatitis C–Specific CD4+ T-cell and cytokine response. Gastroenterology. 121(3). 646–656. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuangsuo Dang Breakdown of academic impact, for papers by Yuki Haga Breakdown of academic impact, for papers by Yuta Wakui Breakdown of academic impact, for papers by Te‐Sheng Chang Breakdown of academic impact, for papers by José María Vera-Cruz Breakdown of academic impact, for papers by Shin Fujioka Breakdown of academic impact, for papers by Takeshi Urabe Breakdown of academic impact, for papers by Jin Ye Breakdown of academic impact, for papers by Janett Fischer
Rankless by CCL
2026